Canary Wharf Group has formed a joint venture with Kadans Science Partner to develop a 750,000 sq ft life science-focused lab.
The wet lab-enabled 22-storey tower will be the the first phase in the creation of a world-leading centre for health and life sciences on the 3.3ha North Quay site, next to the new Elizabeth Line station.
CWG chief executive Shobi Khan said: “Canary Wharf Group has been developing a vision for health and life sciences since 2019 and we are proud to be working with an exceptional partner in Kadans, the European leader in the development and management of life sciences buildings and ecosystems.”
CWG plans to deliver the building, the largest commercial wet lab-enabled life science building in Europe, by 2026.
Khan added that the building would be a laboratory “at its core”, with full flexibility allowing lab space on all floors.
“We are creating a world-class building that will provide state-of-the-art laboratory, office and innovation space for some of the most exciting and fast-growing businesses in the health and life sciences sector,” he said.
The KPF-designed building will leverage Kadans’ experience of curating multi-let lab and office projects with vibrant communities. The building will create a campus under one roof, housing SMEs and academics as well as global healthcare and pharmaceutical companies.
Michel Leemhuis, chief executive of Kadans Science Partner, said: “This joint venture with Canary Wharf Group, which is fully supported by our sponsor and partner AXA IM Alts, provides us with a rare opportunity to not only develop a significant and sustainable new life sciences lab building, which will be the largest in Europe, but also for it to be the catalyst for a new world-leading life sciences cluster and ecosystem in the UK capital.”
Cushman & Wakefield advised CWG; JLL advised Kadans on the joint venture.
Discover which agents are transacting the most space in the Docklands market >>
To send feedback, e-mail piers.wehner@eg.co.uk or tweet @PiersWehner or @EGPropertyNews
